PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 19 filers reported holding PLX PHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | -88.9% | 394 | -69.7% | 0.00% | – |
| Q2 2019 | $9,000 | +50.0% | 1,300 | +8.3% | 0.00% | – |
| Q1 2019 | $6,000 | -82.4% | 1,200 | -85.7% | 0.00% | – |
| Q3 2018 | $34,000 | – | 8,412 | +420500.0% | 0.00% | – |
| Q2 2018 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 1,875,000 | $4,556,000 | 0.28% |
| Ground Swell Capital, LLC | 48,931 | $119,000 | 0.22% |
| Park West Asset Management LLC | 1,473,218 | $3,580,000 | 0.20% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 62,673 | $152,000 | 0.07% |
| Eidelman Virant Capital | 27,000 | $63,000 | 0.04% |
| MBL Wealth, LLC | 52,000 | $126 | 0.03% |
| O'Brien Greene & Co. Inc | 22,340 | $54,000 | 0.02% |
| SHUFRO ROSE & CO LLC | 56,800 | $138,000 | 0.01% |
| GW&K Investment Management, LLC | 424,921 | $1,033,000 | 0.01% |
| EXANE DERIVATIVES | 6,575 | $15,974,000 | 0.01% |